Literature DB >> 20131929

Proinflammatory status, genetics and atherosclerosis.

R Poledne1, A Lorenzová, P Stávek, Z Valenta, J Hubáček, P Suchánek, J Pitha.   

Abstract

Over the last decade, C-reactive protein concentration analyzed by the high sensitivity method (hsCRP) has been proven as a marker of premature atherosclerosis. Concentration exceeding 2 mg/l represents an increased individual risk of myocardial infarction and stroke but strict application of this borderline is complicated by relations of CRP concentrations to other risk factors of cardiovascular diseases. In a large 1 % representative sample of the Czech population, a positive relation of hsCRP to BMI, a waist circumference and triglyceride concentration was documented. Substantial sex differences were found in its relationship to age. Whereas it is continuously increasing in men, this increase appears in women only after menopause. A substantial decrease of body weight and visceral fat volume by increased physical activity is accompanied by significant decrease of hsCRP in young obese women. This decrease was not related to a change of interleukin-6 concentration, although it is supposed to regulate CRP production. CRP concentration is partly under genetic control as a higher concentration in young siblings of probands with proved coronary atherosclerosis was documented. The participation of genes related to lipoprotein metabolism (genes for apolipoprotein CI and apolipoprotein E) influence hsCRP concentrations. We hypothesized that an increased concentration of hsCRP represents a certain marker of proinflammatory status related to central obesity and triglyceride metabolism and it might be related to individual properties of monocytes in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20131929     DOI: 10.33549/physiolres.931915

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  7 in total

1.  Protection of salvianolate against atherosclerosis via regulating the inflammation in rats.

Authors:  Chun Meng; Xiao-Qing Zhuo; Guo-Hong Xu; Jian-Li Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

2.  Lack of an association between connexin-37, stromelysin-1, plasminogen activator-inhibitor type 1 and lymphotoxin-alpha genes and acute coronary syndrome in Czech Caucasians.

Authors:  Jaroslav Alois Hubacek; Vladimír Staněk; Marie Gebauerová; Alexandra Pilipčincová; Rudolf Poledne; Michal Aschermann; Hana Skalická; Jana Matoušková; Andreas Kruger; Martin Pěnička; Hana Hrabáková; Josef Veselka; Petr Hájek; Vera Lánská; Věra Adámková; Jan Pit'ha
Journal:  Exp Clin Cardiol       Date:  2010

3.  Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk.

Authors:  David D McManus; Lea M Beaulieu; Eric Mick; Kahraman Tanriverdi; Martin G Larson; John F Keaney; Emelia J Benjamin; Jane E Freedman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-08-22       Impact factor: 8.311

4.  Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide.

Authors:  Mariellen J Moore; Yan Gong; Wei Hou; Karen Hall; Siegfried O F Schmidt; Robert Whitney Curry; Amber L Beitelshees; Arlene Chapman; Stephen T Turner; Gary L Schwartz; Kent Bailey; Eric Boerwinkle; John G Gums; Rhonda M Cooper-DeHoff; Julie A Johnson
Journal:  Pharmacotherapy       Date:  2014-09-09       Impact factor: 4.705

Review 5.  Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases.

Authors:  Lili Wang; Rufeng Ma; Chenyue Liu; Haixia Liu; Ruyuan Zhu; Shuzhen Guo; Minke Tang; Yu Li; Jianzhao Niu; Min Fu; Sihua Gao; Dongwei Zhang
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 6.  Complementary and Alternative Medicine for Premature Ovarian Insufficiency: A Review of Utilization and Mechanisms.

Authors:  Yang Fu; Dan-Ni Ding; Ying Shen; Li-Yan Jia; Meng-Yu Yan; Wei Wei; Chang-Hong Song; Feng-Juan Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-01       Impact factor: 2.629

7.  The bromodomain inhibitor N-methyl pyrrolidone reduced fat accumulation in an ovariectomized rat model.

Authors:  Bebeka Gjoksi; Chafik Ghayor; Indranil Bhattacharya; Marcy Zenobi-Wong; Franz E Weber
Journal:  Clin Epigenetics       Date:  2016-04-22       Impact factor: 6.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.